Sightful Invest
  • Business
  • Investing
  • Politics
  • Stock
Top Posts
Nasdaq moves into correction territory as Iran war...
FAA investigating close call involving United Airlines plane...
Judge blocks Trump administration from limiting Anthropic’s contracts...
Senate agrees to fund DHS, except ICE and...
Don Jr.’s shadow hangs over Trump mine fight...
AAP faces pressure over trans youth care, guiding...
Spanberger takes fire from all sides as Youngkin,...
House conservatives rage against Senate DHS shutdown deal
Indicted Democrat Rep Sheila Cherfilus-McCormick one step closer...
Biden judge freezes Trump administration’s move against AI...
  • Business
  • Investing
  • Politics
  • Stock

Sightful Invest

Politics

FDA chief counsel who defended abortion pill under Biden resigns 2 days into job

by admin March 13, 2025
March 13, 2025
FDA chief counsel who defended abortion pill under Biden resigns 2 days into job

The Food and Drug Administration’s (FDA) top lawyer, who was appointed to the position just this week, has resigned, according to a Thursday morning post on X.

‘Hilary K. Perkins has resigned from her position as Chief Counsel of FDA, effectively immediately,’ the FDA’s official X account posted.  

Perkins – a former assistant director under Biden’s Department of Justice (DOJ) in the consumer protection agency – was selected on Tuesday by acting general Sean Keveney in the Department of Health and Human Services (HHS) as part of a ‘reorganization’ effort by the department, according to an HHS news release.

She previously defended abortion pill access in a high-profile case under Biden’s DOJ, and HHS officials were reportedly unhappy with the decision to appoint Perkins but were overruled by White House officials, according to a report from Axios this week.

‘We’ve been able to recruit higher quality personnel to HHS than in any time in its history,’ HHS Secretary Robert F. Kennedy, Jr., said in a statement Tuesday at the announcement of Perkins’ assignment on Tuesday. ‘These are individuals who will return the agency to gold-standard science, evidence-based medicine, and recalibrate its trajectory toward public health rather than industry profiteering.’

Fox News Digital has reached out to the HHS and FDA for comment.

This is a breaking story, check back for updates.

This post appeared first on FOX NEWS

previous post
The Hitchhiker’s Guide to where we stand to avoid a government shutdown
next post
Senate Republicans coin ‘Schumer shutdown’ ahead of critical vote on Trump spending bill

You may also like

New ‘insulting’ Harris ad targets Black men’s love...

October 21, 2024

Trump touts massive fundraising haul since winning 2024...

August 27, 2025

58 House Dems vote against resolution honoring ‘life...

September 19, 2025

Hamas reacts to Trump victory, says he must...

November 6, 2024

Elon Musk claims of ‘pork’ in bill not...

July 2, 2025

Harris camp silent on when VP will hold...

August 16, 2024

Who is Karoline Leavitt?: A look at the...

November 30, 2024

Squad member calls for ‘radically’ changing the Supreme...

October 21, 2024

Trump blasts ‘weakened’ Schumer as Democrats again block...

October 15, 2025

Over 200 former Bush, McCain, Romney staffers endorse...

August 28, 2024

Recent Posts

  • Nasdaq moves into correction territory as Iran war weighs on markets
  • FAA investigating close call involving United Airlines plane and Black Hawk helicopter in California
  • Judge blocks Trump administration from limiting Anthropic’s contracts with federal government
  • Senate agrees to fund DHS, except ICE and CBP, in bid to end extreme airport delays
  • Don Jr.’s shadow hangs over Trump mine fight as China retains critical minerals leverage

    Sign up for our newsletter to receive the latest insights, updates, and exclusive content straight to your inbox! Whether it's industry news, expert advice, or inspiring stories, we bring you valuable information that you won't find anywhere else. Stay connected with us!


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Categories

    • Business (998)
    • Investing (4,320)
    • Politics (5,220)
    • Stock (4)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: sightfulinvest.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

    Copyright © 2026 Sightful Invest. All Rights Reserved.